DK0930885T3 - Anvendelsen af heparin eller heparansulfat kombineret med chitosan til forebyggelsen eller behandlingen af infektioner af herpesvirus - Google Patents

Anvendelsen af heparin eller heparansulfat kombineret med chitosan til forebyggelsen eller behandlingen af infektioner af herpesvirus

Info

Publication number
DK0930885T3
DK0930885T3 DK97934838T DK97934838T DK0930885T3 DK 0930885 T3 DK0930885 T3 DK 0930885T3 DK 97934838 T DK97934838 T DK 97934838T DK 97934838 T DK97934838 T DK 97934838T DK 0930885 T3 DK0930885 T3 DK 0930885T3
Authority
DK
Denmark
Prior art keywords
treatment
heparin
chitosan
prevention
combination
Prior art date
Application number
DK97934838T
Other languages
Danish (da)
English (en)
Inventor
Olle Larm
Marcus Back
Tomas Bergstroem
Original Assignee
Medicarb Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medicarb Ab filed Critical Medicarb Ab
Application granted granted Critical
Publication of DK0930885T3 publication Critical patent/DK0930885T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
DK97934838T 1996-08-06 1997-08-01 Anvendelsen af heparin eller heparansulfat kombineret med chitosan til forebyggelsen eller behandlingen af infektioner af herpesvirus DK0930885T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9602931A SE507028C2 (sv) 1996-08-06 1996-08-06 Ny medicinsk användning
PCT/SE1997/001320 WO1998005341A1 (en) 1996-08-06 1997-08-01 The use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus

Publications (1)

Publication Number Publication Date
DK0930885T3 true DK0930885T3 (da) 2002-05-06

Family

ID=20403528

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97934838T DK0930885T3 (da) 1996-08-06 1997-08-01 Anvendelsen af heparin eller heparansulfat kombineret med chitosan til forebyggelsen eller behandlingen af infektioner af herpesvirus

Country Status (13)

Country Link
US (1) US6207653B1 (de)
EP (1) EP0930885B1 (de)
JP (1) JP2000515543A (de)
CN (1) CN1227493A (de)
AT (1) ATE215829T1 (de)
AU (1) AU705189B2 (de)
CA (1) CA2261742A1 (de)
DE (1) DE69711897T2 (de)
DK (1) DK0930885T3 (de)
ES (1) ES2174273T3 (de)
NZ (1) NZ333925A (de)
SE (1) SE507028C2 (de)
WO (1) WO1998005341A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE508760C2 (sv) 1997-04-29 1998-11-02 Medicarb Ab Användning av en komposition innefattande kitosan i kombination med en polysackarid, som aktiv komponent i ett lösningsmedel, för framställning av ett spendoppningsmedel för mjölkproducerande djur
WO2001013910A2 (en) * 1999-08-25 2001-03-01 Massachusetts Institute Of Technology Pharmaceutical preparations for the inhibition of herpes simplex virus 1 entry
US6977248B1 (en) * 1999-08-25 2005-12-20 Massachusetts Institute Of Technology Pharmaceutical preparations for the inhibition of herpes simplex virus 1 entry
SE9904289D0 (sv) * 1999-11-26 1999-11-26 Niklas Arnberg Method and camposition for the treatment of adenovairal ocular infections
US20020119949A1 (en) * 2001-02-26 2002-08-29 Asa Hellman Prophylactic teat treatment
US7968122B2 (en) * 2003-12-10 2011-06-28 Adventrx Pharmaceuticals, Inc. Anti-viral pharmaceutical compositions
EP1774971A1 (de) * 2005-10-14 2007-04-18 Advanced in Vitro Cell Technologies, S.L. Nanopartikel enthaltend Chitosan und Heparin
WO2007069983A1 (en) * 2005-12-13 2007-06-21 Exthera Ab Method for extracorporeal removal of a pathogenic microbe, an inflammatory cell or an inflammatory protein from blood
WO2008155683A1 (en) 2007-06-18 2008-12-24 Firmenich Sa Malodor counteracting compositions and method for their use
CL2008000156A1 (es) * 2008-01-18 2008-08-01 Igloo Zone Chile S A Gel estable hidrofilo en base a un polimero para aplicacion topica porque comprende quitosano disuelto en un solvente; proceso para obtener el gel para uso topico antes mencionado; uso del gel.
AU2010259284A1 (en) * 2009-06-10 2011-12-15 Exthera Ab Use of a composition for the treatment of mucositis
JP5925693B2 (ja) 2009-12-01 2016-05-25 エクステラ・メディカル・コーポレーション 表面固定した多糖類を用いた、血液からのサイトカイン除去法
US20110212181A1 (en) * 2010-02-26 2011-09-01 The University Of Hong Kong Compositions and methods for treating chronic respiratory inflammation
EP3214167A1 (de) * 2010-04-07 2017-09-06 Mitsubishi Gas Chemical Company, Inc. S-adenosyl-l-methionin-haltige trockenhefezusammensetzung mit hervorragender lagerstabilität und herstellungsverfahren dafür
JPWO2011142484A1 (ja) * 2010-05-14 2013-07-22 株式会社日本触媒 ポリアルキレンイミンを含むウイルス感染症治療薬
WO2012112724A1 (en) 2011-02-15 2012-08-23 Exthera Medical, Llc Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines
ES2647577T3 (es) 2012-06-13 2017-12-22 Exthera Medical Corporation Uso de heparina y carbohidratos para tratar el cáncer
CN105339067A (zh) 2013-06-24 2016-02-17 艾克塞拉医疗公司 含有涂覆甘露糖的基质的血液过滤系统
EP3065796B1 (de) 2013-11-08 2020-04-15 ExThera Medical Corporation Verfahren zur diagnose von infektionskrankheiten unter verwendung von adsorptionsmedien
JP2017513636A (ja) 2014-04-24 2017-06-01 エクスセラ メディカル コーポレイション 高流量を用いて血液から細菌を除去するための方法
CA2959975A1 (en) 2014-09-22 2016-03-31 Exthera Medical Corporation Wearable hemoperfusion device
WO2017151797A1 (en) 2016-03-02 2017-09-08 Exthera Medical Corporation Method for treating drug intoxication
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
CN113825517A (zh) 2019-05-16 2021-12-21 艾克塞拉医疗公司 调节内皮糖萼结构的方法
US20230381217A1 (en) * 2020-10-14 2023-11-30 Medoderm Gmbh Liquid composition for use in the prevention or reduction of skin irritation, allergy and/or an infectious disease
WO2023044132A2 (en) * 2021-09-17 2023-03-23 Shawn Walker Use of chitosan complexes or compositions to reduce infiltration of environmental factors into the brain

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU77562A1 (de) * 1977-06-17 1979-03-26 Ciba Geigy Ag Verfahren zur herstellung von neuen pharmazeutischen praeparaten
EP0240098A3 (de) 1986-04-04 1989-05-10 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Oligo und Polysaccharide zur Behandlung von Krankheiten verursacht durch Retroviren
AU1052492A (en) 1991-01-31 1992-08-06 Farmitalia Carlo Erba S.R.L. Synergistic composition comprising a fibroblast growth factor and a sulfated polylsaccharide, for use as antiviral agent

Also Published As

Publication number Publication date
ATE215829T1 (de) 2002-04-15
AU3791197A (en) 1998-02-25
JP2000515543A (ja) 2000-11-21
DE69711897T2 (de) 2002-08-22
CN1227493A (zh) 1999-09-01
CA2261742A1 (en) 1998-02-12
SE9602931L (sv) 1998-02-07
ES2174273T3 (es) 2002-11-01
EP0930885A1 (de) 1999-07-28
SE507028C2 (sv) 1998-03-16
AU705189B2 (en) 1999-05-20
WO1998005341A1 (en) 1998-02-12
US6207653B1 (en) 2001-03-27
NZ333925A (en) 2000-07-28
EP0930885B1 (de) 2002-04-10
SE9602931D0 (sv) 1996-08-06
DE69711897D1 (de) 2002-05-16

Similar Documents

Publication Publication Date Title
SE9602931D0 (sv) New medicinal use
EE04605B1 (et) Taime ja surfaktanti sisaldav kompositsioon ning selle kasutamine lihtherpese viiruse ja teiste nakkushaiguste raviks ette nähtud ravimtoote valmistamiseks
BR9913406A (pt) Processo de tratamento de infecção causada por pelo menos um vìrus da famìlia flaviviridae e de doença associada com a citada infecção em um hospedeiro vivo possuindo a citada infecção
BR9606769A (pt) Tablete e processos para tratamento de uma infecção de vírus do herpes em um humano e para preparação do tablete
FI904445A0 (fi) Antivirala foereningar.
EP1852121A3 (de) Flüssige Analoge zur Behandlung viraler Infektionen
EP0652011A4 (de) Prophylaktisches mittel und arzneimittel für virale erkrankungen der atemwege.
ZA931035B (en) Sulfonic acid derivatives in the treatment of viral diseases.
PT98565A (pt) Um processo de producao de uma composicao para o tratamento da infeccao por hsv
EP1670507A4 (de) Vakzine zur behandlung und prävention von herpes simplex-virusinfektion
EP0382551A3 (en) Prevention and treatment of herpes virus infections
LV10191A (lv) Farmaceitiski lidzekli hepatita B virusa izraisito infekciju un slimibu arstesanai
BR9916043A (pt) Composto, uso do mesmo e de seus saisfarmaceuticamente aceitáveis, e, composiçãofarmacêutica para tratamento de infecções deherpes viral em pacientes
GB8926595D0 (en) Pharmaceutical compositions for use in the treatment herpes simplex virus infections
SE9303612D0 (sv) New use
ES2162862T3 (es) Uso de la timosina para tratar la hepatitis c en pacientes que no responden al tratamiento con interferon.
NO972688D0 (no) Anvendelse av aminopurin-antivirale-midler for behandling og profylakse av latente herpesvirus-infeksjoner
DE69925312D1 (de) Bupropion zur behandlung von viralen erkrankungen
BG100835A (bg) Ново лекарствено средство за лечение на вирусни инфекции на дихателните пътища
EP0342565A3 (de) Verwendung des Thiazol-Derivates Tiprotimod zur Herstellung eines Mittels zur Therapie von Virusinfektionen
CA2082270A1 (en) Anti-viral therapy
IT1178809B (it) Comosto di tetraetilammonio per l uso nel trattamento di malattie provocate da virus erpetici
WO2001013910A3 (en) Pharmaceutical preparations for the inhibition of herpes simplex virus 1 entry
EP1143981A4 (de) Behandlung und vorbeugung von hiv- und anderen virus infektionen
DK0728002T3 (da) Anvendelse af 2-aminopurinderivater til behandling og forebyggelse af humant herpesvirus 7-infektioner